CG Bio Acquires Majority Stake in Innosys
The acquisition will leverage Innosys' R&D in the spine segment, synergizing with CG Bio's orthobiologic and spinal devices....
The acquisition will leverage Innosys' R&D in the spine segment, synergizing with CG Bio's orthobiologic and spinal devices....
Zeda will produce OIC’s implant designs, fortifying and accelerating its mission to provide accessible trauma implants to patients on a...
CartiHeal is the developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee....
Enovis’ $844 million acquisition of LimaCorporate is expected to elevate the company’s recon segment to $1 billion in annual sales....
The company will acquire a majority interest in TriMed and enter a strategic relationship with Extremity Medical....
The transaction will allow ZimVie to streamline operations and sharpen its focus as a well-positioned, pure-play dental company in higher-growth...
SERF is recognized worldwide for its innovations in hip implants, including the invention of the original Dual Mobility Cup....
Orthopedic M&A is more active and has higher multiples than general medtech, but economic conditions will limit growth for now....
Vyrsa manufactures and supports a complete portfolio of FDA-cleared sacroiliac joint fusion devices....
TeDan produces surgical access systems with a specialty focus in spine, neuro, orthopedic and cardiothoracic surgery....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.